Other
Long-Term Debt and Lease Obligation
Thermo Fisher Scientific Long-Term Debt and Lease Obligation increased by 11.8% to $40.07B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.7%, from $31.37B to $40.07B. Over 5 years (FY 2020 to FY 2025), Long-Term Debt and Lease Obligation shows an upward trend with a 13.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
Metric ID:
other_long_term_debt_and_capital_lease_obligationsHistorical Data
19 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.69B | $32.33B | $31.39B | $29.25B | $28.15B | $28.91B | $29.14B | $29.19B | $30.49B | $31.31B | $31.16B | $30.28B | $31.2B | $29.06B | $31.37B | $33.02B | $31.86B | $35.85B | $40.07B |
| QoQ Change | — | +49.1% | -2.9% | -6.8% | -3.8% | +2.7% | +0.8% | +0.2% | +4.4% | +2.7% | -0.5% | -2.8% | +3.0% | -6.8% | +7.9% | +5.2% | -3.5% | +12.5% | +11.8% |
| YoY Change | — | — | — | — | +29.8% | -10.6% | -7.2% | -0.2% | +8.3% | +8.3% | +6.9% | +3.7% | +2.3% | -7.2% | +0.7% | +9.0% | +2.1% | +23.4% | +27.7% |
Range$21.69B – $40.07B
CAGR+14.6%
Avg YoY Growth+6.5%
Median YoY Growth+3.7%
Current Streak2 quarters growth
Long-Term Debt and Lease Obligation at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's long-term debt and lease obligation?
- Thermo Fisher Scientific (TMO) reported long-term debt and lease obligation of $40.07B in Q1 2026.
- How has Thermo Fisher Scientific's long-term debt and lease obligation changed year-over-year?
- Thermo Fisher Scientific's long-term debt and lease obligation increased by 27.7% year-over-year, from $31.37B to $40.07B.
- What is the long-term trend for Thermo Fisher Scientific's long-term debt and lease obligation?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's long-term debt and lease obligation has grown at a 13.4% compound annual growth rate (CAGR), from $19.11B to $35.85B.